Exxon Mobil, Chevron, and More: Billionaire Druckenmiller’s Energy Stock Picks

Page 1 of 2

We have already gone through billionaire Stanley Druckenmiller’s 13F filing for the third quarter of 2012. Even though investors can’t buy all of these stocks, we still think that it can be useful to use these picks as free ideas that can be researched further- or not- as an investor wishes. Our database of filings also allows us to narrow our focus to specific sectors, industries, and valuation categories, and the same logic applies there. See the full list of stocks from Druckenmiller’s 13F or read on for our quick take on the five largest energy holdings in his portfolio:


Druckenmiller initiated a position of 1.3 million shares in Exxon Mobil Corporation (NYSE:XOM), making the supermajor of all supermajors the largest holding in his 13F portfolio. Exxon Mobil currently has a market capitalization of just over $400 billion, which places its valuation at 11 times consensus earnings for 2013. That multiple also reflects an expected decline in net income next year. Exxon Mobil made our list of the ten most popular energy stocks for the third quarter (see the full rankings). In the third quarter revenue and earnings at the company were down 7-8%, but we’d consider it as a long term value stock as long as an investor can handle the exposure to oil and gas prices.

Another new addition to the portfolio was Chevron Corporation (NYSE:CVX), another large oil and gas company. Its market cap is about half of Exxon Mobil’s. Chevron also experienced a decline in revenue and earnings last quarter versus a year earlier, though the drop was steeper there: net income, for example, fell by about a third. However, the market gives Chevron an appropriate discount to its larger peer and the trailing and forward P/E multiples both come in at 9. Billionaire Ken Fisher’s Fisher Asset Management added heavily to its position in Chevron last quarter (check out Fisher’s stock picks) and we think that it is worth considering as well.

Page 1 of 2

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!